Loading...
Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
Zoledronic acid, a bisphosphonate, has been approved for treatment and prevention of osteoporosis. This case describes a 73-year-old woman with primary osteoporosis who developed transient hepatotoxicity after zoledronic acid (ZOL) treatment. Three days after ZOL infusion, aspartate aminotransferase...
Na minha lista:
| Udgivet i: | EXCLI J |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Leibniz Research Centre for Working Environment and Human Factors
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4803018/ https://ncbi.nlm.nih.gov/pubmed/27034632 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|